1. Home
  2. TARS vs HP Comparison

TARS vs HP Comparison

Compare TARS & HP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARS
  • HP
  • Stock Information
  • Founded
  • TARS 2016
  • HP 1920
  • Country
  • TARS United States
  • HP United States
  • Employees
  • TARS N/A
  • HP N/A
  • Industry
  • TARS Medicinal Chemicals and Botanical Products
  • HP Oil & Gas Production
  • Sector
  • TARS Health Care
  • HP Energy
  • Exchange
  • TARS Nasdaq
  • HP Nasdaq
  • Market Cap
  • TARS 1.8B
  • HP 1.9B
  • IPO Year
  • TARS 2020
  • HP N/A
  • Fundamental
  • Price
  • TARS $40.65
  • HP $17.10
  • Analyst Decision
  • TARS Strong Buy
  • HP Hold
  • Analyst Count
  • TARS 7
  • HP 11
  • Target Price
  • TARS $67.14
  • HP $27.60
  • AVG Volume (30 Days)
  • TARS 552.3K
  • HP 2.4M
  • Earning Date
  • TARS 08-07-2025
  • HP 07-23-2025
  • Dividend Yield
  • TARS N/A
  • HP 5.79%
  • EPS Growth
  • TARS N/A
  • HP N/A
  • EPS
  • TARS N/A
  • HP 2.20
  • Revenue
  • TARS $233,674,000.00
  • HP $3,084,858,000.00
  • Revenue This Year
  • TARS $122.94
  • HP $38.00
  • Revenue Next Year
  • TARS $44.14
  • HP $5.91
  • P/E Ratio
  • TARS N/A
  • HP $7.87
  • Revenue Growth
  • TARS 449.03
  • HP 12.23
  • 52 Week Low
  • TARS $20.08
  • HP $14.65
  • 52 Week High
  • TARS $57.28
  • HP $42.60
  • Technical
  • Relative Strength Index (RSI)
  • TARS 40.26
  • HP 45.88
  • Support Level
  • TARS $39.25
  • HP $17.39
  • Resistance Level
  • TARS $42.01
  • HP $18.80
  • Average True Range (ATR)
  • TARS 1.93
  • HP 0.94
  • MACD
  • TARS -0.05
  • HP 0.21
  • Stochastic Oscillator
  • TARS 22.95
  • HP 44.70

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About HP Helmerich & Payne Inc.

Helmerich & Payne Inc provides performance-driven drilling solutions and technologies that are intended to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. The Company focus on the drilling segment of the oil and gas production value chain. Company operates in North America, Gulf of Mexico, and other international places such as Argentina, Australia, Bahrain, Colombia and the United Arab Emirates (UAE). Also own and operates a limited number of commercial real estate properties located in Tulsa, Oklahoma. It's real estate investments include a shopping center and of undeveloped real estate projects.

Share on Social Networks: